Global Peripheral Artery Disease Market to be driven by Rise in Geriatric Population

Published Date : May 16, 2016

ALBANY, New York, May 16, 2016: has added a new research report to its repository. The report, titled “Global Peripheral Artery Disease Market Report: 2016 Edition,” offers a detailed study on the global peripheral artery disease market and points out the key factors impacting the growth of the market. The causes and various treatment options for peripheral artery disease have been described in the report. The report assesses the future outlook of the global peripheral artery disease market with the help of primary and secondary research methodologies as well as analytical tools. The growth of the market has been studied across some of the key regions. Profiles of leading market players have been included in the report.

Peripheral artery disease, better known as PAD, leads to plaque building up inside the walls of the arteries, thereby blocking the flow of blood to the stomach, arms, and legs. High blood pressure, smoking, diabetes, advancing age, abnormal cholesterol levels, and a family history of vascular diseases are the key factors causing peripheral artery disease. Patients suffering from severe PAD often develop ulcers in their legs and feet. Other symptoms of the disease are cramp-like muscular discomfort, tingling, numbness, fatigue, and weakness. The key treatment options for peripheral artery disease include drug-coated balloons (DCB), percutaneous trans luminal angioplasty (PTA), stents, atherectomy, arterial bypass, and drug-eluting stents (DES).

The report points out that the rise in geriatric and obese population has boosted the growth of the global peripheral artery disease market. A rise in healthcare expenditures across the emerging economies and the growing usage of drug-coated balloons in the U.S. have further fuelled the market’s growth. However, the increased usage of drug-coated balloons might eat into the demand for peripheral artery disease devices. Limitations of peripheral interventions will also challenge the market growth in the near future. The overall peripheral artery disease market has a huge scope to grow on account on favorable reimbursement policies.

For Sample Copy, click here:

The report studies the global peripheral artery disease market across two key regions: the U.S. and the European Union. The report analyzes the growth of these regional markets in terms of the number of diagnosed cases, and the usage of stents and drug-coated balloons. The report further assesses the valuation of the global peripheral atherectomy market.

Describing the competitive hierarchy, the report profiles some of the key players in the global peripheral artery disease market such as Medtronic Plc., Cardiovascular Systems Inc., Spectranetics Corp., and Boston Scientific Corporation. The report further provides detailed information about the players including their financial overview, business overview, and business strategies. The global peripheral artery disease market is quite fragmented with larger companies registering huge profits while smaller players are trying to increase their market shares through research and development.

To order report Call Toll Free: 866-997-4948 or send an email on